NCT02320123

Brief Summary

Racial differences in health care are documented across the health care continuum and persist in aging and end-of-life (EOL) care. African Americans (AA) and other underrepresented minorities often choose more aggressive therapies at the end of life and are less likely to utilize hospice care in the terminal stages of their illness. Potential reasons for these disparities include: lack of knowledge of and misperceptions about palliative and hospice care, spiritual beliefs, and mistrust in the health care system, among others. Despite the literature on disparities in end-of-life (EOL) care and reasons for underuse and the presence of national EOL care guidelines, attempts to address this problem have been limited and often not rigorously evaluated. The majority of interventions to promote EOL care were done in majority populations and focused predominantly on trying to change physician awareness of patient's pain, symptoms, and values or to change physician communication behavior. While these early studies made tremendous contributions to the study of EOL care and the needs of the terminally ill, the interventions associated with these studies did not reach their desired effectiveness. The investigators propose a different strategy that would focus specifically on previously identified barriers to utilization of advance directives, palliative care, and hospice care among African Americans - including physicians' difficulty and discomfort with prognostication, AA patients' knowledge, attitudes and beliefs towards hospice and palliative care, conflict between patients' spiritual beliefs and the general hospice and palliative medicine philosophy of care, and medical mistrust. The goal of this project is to improve methods of prognostication for physicians and increase awareness of EOL care options for AAs. To overcome the dual challenges of physicians' reluctance to discuss EOL care and patients' discomfort in engaging in such conversations, the investigators will use the electronic medical record (EMR) to automatically identify AA patients with life-limiting illness who are eligible for counseling about EOL care options. To change knowledge and attitudes toward EOL care options among AA patients, the investigators will design a culturally sensitive intervention that will combine multimedia materials and a culturally concordant lay health advisor who will deliver tailored education and counseling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
1.4 years until next milestone

Study Start

First participant enrolled

May 23, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2017

Completed
3 years until next milestone

Results Posted

Study results publicly available

August 12, 2020

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

1.2 years

First QC Date

December 15, 2014

Results QC Date

October 26, 2017

Last Update Submit

August 11, 2020

Conditions

Keywords

Terminal CareDecision MakingCommunication

Outcome Measures

Primary Outcomes (4)

  • Intent to Discuss Advance Directives (Based on the Transtheoretical Stages of Change Model)

    The primary decision-making outcome is change in intent to discuss advance directives based on the Transtheoretical Stages of Change Model (i.e., pre-contemplation, contemplation, preparation, action, and maintenance).

    Within six months after patient enrolls in study, June 2017.

  • Intent to Discuss Medical Power of Attorney (Based on the Transtheoretical Stages of Change Model)

    The primary decision-making outcome is change in intent to discuss medical power of attorney based on the Transtheoretical Stages of Change Model (i.e., pre-contemplation, contemplation, preparation, action, and maintenance).

    Within six months after patient enrolls in study, June 2017.

  • Intent to Discuss Palliative Care (Based on the Transtheoretical Stages of Change Model)

    The primary decision-making outcome is change in intent to discuss palliative care based on the Transtheoretical Stages of Change Model (i.e., pre-contemplation, contemplation, preparation, action, and maintenance).

    Within six months after patient enrolls in study, June 2017.

  • Intent to Discuss Hospice Care (Based on the Transtheoretical Stages of Change Model)

    The primary decision-making outcome is change in intent to discuss hospice care based on the Transtheoretical Stages of Change Model (i.e., pre-contemplation, contemplation, preparation, action, and maintenance).

    Within six months after patient enrolls in study, June 2017.

Secondary Outcomes (5)

  • Quality of Life at the End of Life

    Within six months after patient enrolls in study, June 2017.

  • Health Care Utilization: Emergency Room

    Within six months after patient enrolls in study, June 2017.

  • Number of Patients Who Died

    Within six months after patient enrolls in study, June 2017.

  • Utilization of Advance Care Planning and End-of-life Care

    Within six months after patient enrolls in study, June 2017.

  • Health Care Utilization: Mean Number of Hospitalizations in Six Months by Group

    Within six months after patient enrolls in study, June 2017.

Study Arms (2)

Patients - intervention

EXPERIMENTAL

For the intervention arm of the study, patients will be invited to view the educational DVD explaining end-of-life care options and meet with a lay health advisor for discussion.

Behavioral: Educational DVD

Patients - Control

NO INTERVENTION

Patients will receive usual care (nor view the DVD or meet with the lay health advisor).

Interventions

Educational DVDBEHAVIORAL

African American patients and their primary non-professional caregivers will watch a DVD created to introduce end-of-life care planning to African Americans receiving palliative care.

Patients - intervention

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aim 1 patients must:
  • receive their care at Parkland and be diagnosed with advanced cancer (breast, lung, or colon);
  • self-identify as AA;
  • be proficient in English;
  • be competent to give informed consent; and
  • have no evidence of cognitive impairment (Mini-Cog score of ≥3 or 1-2 with normal clock draw).
  • Aim 2 Patients must:
  • be hospitalized at Parkland
  • be diagnosed with advanced cancer (breast, lung, or colon)
  • self-identify as AA;
  • be proficient in English;
  • be competent to give informed consent;
  • have no evidence of cognitive impairment (Mini-Cog score of ≥3 or 1-2 with normal clock draw); and
  • have never received palliative or hospice care.
  • All Caregivers (Aim 1 and 2) must be:
  • +6 more criteria

You may not qualify if:

  • For patients:
  • identify with a race other than African American or
  • have a diagnosis other than advanced breast, lung, or colorectal cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Hospital

Dallas, Texas, 75235, United States

Location

MeSH Terms

Conditions

Colonic NeoplasmsBreast NeoplasmsLung NeoplasmsCommunication

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesBehavior

Results Point of Contact

Title
Dr. Ramona Rhodes
Organization
UT Southwestern Medical Center

Study Officials

  • Ethan Halm, MD

    Chair, Department of General Internal Medicine

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The research staff conducting assessments for all participants was masked to patients receiving the intervention as well as those assigned to the control group.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

December 15, 2014

First Posted

December 19, 2014

Study Start

May 23, 2016

Primary Completion

August 10, 2017

Study Completion

August 10, 2017

Last Updated

August 12, 2020

Results First Posted

August 12, 2020

Record last verified: 2020-08

Locations